Rep. Jason Crow (D-Colo.) on Wednesday demanded U.S. Attorney for the District of Columbia Jeanine Pirro preserve all evidence related to her unsuccessful effort to bring charges against him and five other Democratic lawmakers.

The request comes a day after Pirro’s office failed to obtain a criminal indictment against the lawmakers for putting out a video last year urging military personnel not to carry out illegal orders.

In a letter sent Wednesday to Pirro’s office, Abbe Lowell, Crow’s attorney, called the effort to indict Crow and the other Democrats involved in the video “a breathtaking and unprecedented level of prosecutorial overreach and misuse of power.” Lowell, who has represented a wide swath of President Donald Trump’s enemies in the last year, also put Pirro and other federal prosecutors “on notice” of the possible legal ramifications for failing to preserve evidence in the case or taking further action to pursue the case.

“Donald Trump’s abuse of America’s justice system is chilling and indefensible,” Lowell wrote in the letter. “What’s perhaps most surprising is not that your effort to secure a grand jury indictment failed, but that you even tried. Americans are paying attention to your gross abuses of power and demanding accountability.

Pirro’s office did not immediately respond to a request for comment.

Pirro and other prosecutors in the Trump administration have on several occasions struggled to secure indictments against several of the president’s political foes, including New York Attorney General Letitia James and former FBI Director James Comey. A grand jury rejecting indictments is an exceedingly rare outcome in federal cases, as they are tasked only with determining whether the Justice Department has brought a plausible case, although the Trump administration has faced an unusual number of failures in liberal areas like New York and the D.C. area.

Sens. Mark Kelly of Arizona and Elissa Slotkin of Michigan, whom federal prosecutors also attempted to indict in relation to the video, decried the move from Pirro’s office at a Wednesday press conference, with Kelly calling it an effort “to abuse power in order to silence and intimidate anyone who disagrees with them.”

“The baseless and absurd allegations by Donald Trump, followed by your carrying out of the President’s political retribution campaign has already gone too far, and are evidence of yet another abuse of power directed at those who dare speak out and criticize this Administration,” Lowell wrote in the letter, which was first reported by CBS News.

Trump, in the wake of the video’s release in November 2025, repeatedly called for the lawmakers to face arrest and trial for what he called “SEDITIOUS BEHAVIOR, punishable by DEATH!” The president later clarified that he was “not threatening death” against the Democrats.

Speaker Mike Johnson says he has asked retiring Rep. Neal Dunn to serve out his term amid concerns the Florida Republican might resign early.

An early exit from Dunn, 72, would deal Johnson another massive blow as he tries to maintain his narrow majority. Currently, Republicans can afford to lose no more than one GOP vote on party-line measures, though they are expected to pick up a vote in a March special election.

Senior House Republicans believe he intends to step down in the coming months despite an effort to get him to stay, according to three people granted anonymity to describe the private discussions.

“Neal Dunn is a beloved member of Congress and a great man, and you know, he’s informed us he’s not going to run for reelection,” Johnson told reporters Wednesday. As for what Dunn does beyond that, he added, “I’m not sure — you need to ask him about it. But I’ve encouraged him to stay and be a part of this, and I think he wants to do that.”

Dunn, who represents a heavily Republican seat in northern Florida, declined to discuss his intentions in an interview Wednesday: “No comment,” he said.

Dunn has worn a mask on the House floor at times in recent weeks, and some of his colleagues said they believe his health is a factor in his decision. Asked about those concerns, Dunn replied, “Don’t I look good?”

Some Senate Republicans emerged disappointed from a closed-door briefing Tuesday with FDA Commissioner Marty Makary, saying the agency is not taking a safety review of the abortion pill mifepristone seriously and calling for congressional action to curb access to the drug.

Sen. Josh Hawley (R-Mo.) said in an interview Makary failed to give a timeline for completion of the review, explain what the audit will involve and disclose whether it was even underway.

“I think that this safety study is a dead end,” Hawley said. “I just think that FDA is not serious about it. I don’t think that they’re proceeding with any sense of urgency whatsoever. If they’re really proceeding at all. I frankly, can’t tell.”

Sen. Bill Cassidy (R-La.), the chair of the Senate Health, Education, Labor and Pensions Committee who organized the briefing for select GOP senators, in a statement also blasted “the lack of progress on HHS and FDA’s promised safety study on these dangerous drugs” as “disappointing,” and complained the review was “moving too slowly.”

It’s not clear what comes next. Republicans have previously tried and failed to impose restrictions on mifepristone, which is used in more than two-thirds of abortions, through government funding legislation. Hawley said he has not yet decided whether to attempt to place guardrails on the drug as part of the next appropriations process or introduce standalone a standalone bill but that he will roll out his plans in the coming weeks.

“I don’t have confidence [the FDA review] is going to amount to anything,” he said. “My view is Congress now needs to get involved.”

Reached for comment, HHS spokesperson Andrew Nixon referred Blue Light News to a previous agency statement asserting the FDA “is taking care to do this study properly and in the right way.”

“We are planning to complete the study as soon as possible while ensuring we are not cutting any corners from a scientific research standpoint,” the statement reads, adding that such reviews “often take approximately a year or more to conduct.”

Conservative anger with the Trump administration has boiled over in recent months over its decision to leave in place Biden-era rules that expanded access to abortion pills via mail and telemedicine, and for approving a new generic version of the drug. Administration officials took narrower steps in January to roll back access to mifepristone at retail pharmacies, but the anti-abortion movement and their allies in Congress are pressuring the FDA to abolish telemedicine prescription of the pills or ban them altogether.

At the same time, several GOP states are suing the agency, including Cassidy’s Louisiana and Hawley’s Missouri. The Trump administration has tried to rebuff these lawsuits, asking judges to wait until FDA’s ongoing study is completed before issuing a ruling. Anti-abortion activists, tired of waiting, have threatened to withhold resources from the GOP in the upcoming midterm elections if they don’t see action on the drugs.